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Health researchers have, to a large extent, neglected the issue
of over-the-counter (OTC) and prescription medicine misuse.
As a result, there is little available information on the global
prevalence of licit medicine misuse. (Prescription/OTC
medicine abuse/misuse refers to use for reasons not medically
indicated, in doses higher than recommended or for a longer
than recommended duration to achieve a psychoactive effect.)
Although many OTC and prescription medicines have the
potential to be misused, prescription benzodiazepines and
OTC/prescription analgesics are two of the most widely
misused classes of medicines.
Globally, benzodiazepines are among the most commonly
prescribed medicines.  When used appropriately, these
sedative-hypnotics are effective in treating a range of medical
conditions.1 However, the misuse of benzodiazepines is
widespread, with the 1998 National Household Survey on
Drug Abuse (NHSDA)2 reporting a lifetime prevalence of 5.6%
for benzodiazepine misuse among Americans aged 12 years or
older. Benzodiazepine misuse may result in transient side-
effects, including psychomotor retardation, cognitive
dysfunction, disinhibition, and emotional blunting.1 The misuse
of benzodiazepines together with other central nervous system
(CNS) depressants places the user at risk of overdose and
death.1 In addition, a long-term consequence of
benzodiazepine misuse is psychological and physiological
dependence, manifest in a distinctive benzodiazepine
withdrawal syndrome.3
Both prescription and OTC analgesics have widespread
application in the treatment and management of pain.
However, evidence points to the widespread misuse of these
substances, with the 1998 NHSDA reporting a lifetime
prevalence of 5.3% for the non-medical use of prescription
analgesics among Americans aged 12 years or older.2
Prescription and OTC analgesics can be broadly grouped into
one of two categories: opioid analgesics (e.g. morphine and
codeine) and non-narcotic analgesics. Opioid analgesics act as
CNS depressants, hence large doses may result in respiratory
s u p p ression, seizures, coma, and potentially death.  Al o n g - t e r m
health outcome of opioid analgesic misuse is psychological and
physical dependence.4 The chronic misuse of non-narcotic
analgesics is associated with analgesic-induced headaches,5
gastrointestinal problems,4 analgesic nephropathy, and
atherogenesis that may result in premature mortality.6
Despite the abuse potential of OTC and prescription
medications documented by prospective studies of the general
populations in countries like the USA, there is little research
describing the prevalence of OTC/prescription medicine
misuse in South Africa.  The aim of this paper is to begin to
address this gap by providing retrospective, community-level
public health surveillance information on OTC/prescription
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Objective. To provide community-level public health
surveillance information on over-the-counter (OTC) and
prescription medicine misuse.
Methods. A retrospective study of OTC and prescription
medicine misuse among 9 063 patients from 23 specialist
substance abuse treatment centres in Cape Town, South
Africa, between 1998 and 2000.
Results. OTC and prescription medicine misuse places a
burden on health and social services in South Africa. This is
evidenced through the constant demand for treatment for
OTC/prescription medicine misuse. Benzodiazepines are the
class of medicines for which users most often receive
treatment, followed by analgesics. Analgesic misuse is most
often accounted for by the use of codeine-containing
medicines, many of which are available over the counter.
Patients using OTC/prescription medicines as their primary
drug of abuse are significantly more likely to be female, and
aged over 40 years. In contrast, patients using
OTC/prescription medicine as an additional drug of abuse
tend to be male and over 40 years of age.
Conclusions. This study points to the need to develop primary
health care protocols for detection, management and referral
of patients misusing OTC/prescription drugs and the need to
debate the re-scheduling of codeine as a prescription-only
substance. The study also points to the need for further
community-based research on the nature and extent of
OTC/prescription drug misuse among the general
population.
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medicine misuse among people attending specialist substance
abuse treatment facilities in Cape Town.
Method
As part of the South African Community Epidemiology
Network on Drug Use (SACENDU) project, data on OTC and
prescription medicine misuse are collected biannually from 23
specialist substance abuse treatment centres in Cape Town.7
These sites represent at least 95% of the specialist treatment
centres in Cape Town. Treatment centres include state-funded,
private, and non-government institutions. A standardised one-
page form is completed on each person treated by a given
centre during a particular 6-month period. The form elicits
biographical information as well as information on the types of
substances abused and patterns of substance abuse. Regular
training in data collection procedures is given to staff at
treatment centres.  To ensure data quality, completed forms are
checked for missing information and possible miscodes.
Of the 9 063 forms collected over 6 collection periods
between 1998 and 2000, those referring to OTC/prescription
medicine as drugs of abuse were selected for further analysis.
Using the South African Medicines Formulary ,8 all
OTC/prescription medicine mentions were re-coded as
benzodiazepines, analgesics, slimming preparations, or
unspecified medicines. Medicines coded as analgesics were
further coded as codeine-containing, other opioid, or
unspecified medicines.  Each form represents a single treatment
episode for a specific person.  
Results
From 1998 to 2000, 710 (7.8%) of the 9 063 cases recorded by
specialist treatment centres in Cape Town reported OTC,
prescription, or unspecified medicines as the primary or
secondary substance(s) of abuse (Fig. 1).
OTC/prescription medicines as primary substances
of abuse
OTC and prescription medicines were reported as primary
substances of abuse by 239 (2.6%) of the 9 063 cases. Of these
239 cases, 111 (46.4%) reported benzodiazepines and 107
(44.8%) reported analgesics as their primary substances of
abuse (Fig. 1).
Significantly more females than males reported abusing
OTC/prescription medicine as their primary drug of abuse (c 2
9 063 cases recorded across 23 treatment centres
OTC/prescription drugs as primary and secondary drugs of abuse 
N = 710 (7.8%)
Other drugs of abuse 
N = 3 853 (92.2%)
Benzodiazepines
N = 111 (46.4%)
Analgesics
N = 107 (44.8%)
Codeine-containing
N = 57 (53.3%)
Codeine-containing
N = 57 (40.4%)
Other opioid
N = 31 (28.9%)
Other opioid
N = 36 (25.5%)
Unspecified
N = 19 (17.8%)
Unspecified
N = 15 (26.3%)
OTC
N = 17 (29.8%)
Prescription
N = 25 (43.9%)
Unspecified
N = 48 (34.1%)
Slimming preparations
N = 8 (3.3%)
Slimming preparations




N = 38 (8.1%)
Benzodiazepines
N = 268 (56.9%)
Analgesics
N = 141 (29.9%)
OTC/prescription drugs as primary drugs of abuse
N = 239 (33.7%)
OTC/prescription drugs as additional drugs of abuse
N = 471 (66.3%)
Fig. 1. OTC and prescription drug misuse in Cape Town, 1998 - 2000.
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= 4.648, p = 0.031). Of the 111 patients reporting
benzodiazepines as their primary substance of abuse, 74
(66.7%) were female.  Similarly, of the 107 people citing
analgesics as their primary substance of abuse, 56 (52.3%) were
female.   Some 63 (57.2%) of the 111 patients reporting
benzodiazepines as their primary drugs of abuse, and some 41
(38.6%) of the 107 people reporting analgesics as their primary
drug of abuse, were older than 40 years of age.  
Among the 107 people reporting analgesics as their primary
drug of abuse, 57 (53.3%) abused codeine-containing
preparations, of which 43.9% were prescription, 29.8% were
OTC, and 26.3% were unspecified medicines. Other opioid
analgesics were misused by 28.9% of the patients within this
group, of which all were prescription medicines (Fig. 1). 
OTC/prescription medicines as secondary
substances of abuse
OTC/prescription medicines were cited as secondary
substances of abuse by 471 (5.2%) of the 9 063 cases.
Benzodiazepines were the most frequently reported licit
medicines misused, followed by analgesics (Fig. 1). Some 62
(13.2%) of the 471 patients reported the additional misuse of
other medicines that included slimming preparations,
antidepressants (e.g. fluoxetine), stimulants (e.g.
methylphenidate), and anaesthetics (e.g. ketamine).
Between 1998 and 2000, 174 (64.8%) of the 268 patients
reporting using benzodiazepines and 88 (62.1%) of the 141
patients citing analgesics as secondary substances of abuse
were male. In terms of age, 117 (43.8%) patients with
benzodiazepines and 64 (45.2%) patients with analgesics as
secondary substances of abuse were 40 years of age or older.
Of the 268 patients reporting benzodiazepines as their
secondary substance of abuse, 154 (57.5%) cited alcohol, 38
(14.3%) cited cocaine, 15 (5.5%) reported heroin, and 15 (5.5%)
cited Mandrax (methaqualone) or Mandrax smoked together
with cannabis (white pipes) as their primary substance of
abuse. Of the 141 patients reporting analgesics as secondary
drugs, 57 (40.4%) reported the misuse of codeine-containing
preparations, of which 33 (57.9%) were OTC preparations.
Some 36 patients (25.5%) reported the misuse of other opioid
analgesics, of which 100% were prescribed medicines (Fig. 1).
Of the 114 patients reporting analgesics as their secondary
substance of abuse, 53 (46.2%) cited alcohol, 20 (17.9%) cited
benzodiazepines, 10 (8.3%) reported heroin, 10 (8.3%) cited
cannabis, and 10 (8.3%) cited methaqualone as their primary
substance of abuse.  
Discussion
The findings from our study confirm that OTC/prescription
medicine misuse is frequently reported among patients in
substance abuse treatment settings. Compared with most illicit
drugs, OTC/prescription medicines are relatively inexpensive,
and easy to procure, and possession holds no legal sanction.
Many people do not perceive the inappropriate use of
OTC/prescription medicines to be as problematic as the use of
illicit drugs, which are thought to have greater potential to
cause harm.1 However, at least for a small proportion (2.6%) of
the 9 063 cases studied in Cape Town, OTC/prescription
medicine misuse was the primary problem for which patients
sought substance abuse treatment services.  In addition, the
misuse of OTC/prescription medicines in combination with, or
in addition to, a primary substance of abuse (commonly
alcohol) was cited by 5% of all cases. This pattern of combining
medicines with other substances is cause for concern as it is
associated with serious health consequences, including coma
and death.1
Significantly more females than males reported
OTC/prescription medicines as their primary substance of
abuse. A partial explanation for this contrast may lie in the use
of benzodiazepines to treat the high prevalence of anxiety and
mood disorders among women.9 For many women it may also
be more socially acceptable to use OTC/prescription medicines
than other substances.
Consistent with findings from studies conducted in the USA
and Europe,1,2 benzodiazepines are the most widely misused
medicines in Cape Town.   Also in keeping with international
findings,9-11 the majority of substance-abusing patients use
benzodiazepines in addition to their primary drug of abuse,
which is most likely to be alcohol. For these patients,
benzodiazepines may be used to enhance the effect of the
primary drug of abuse or to alleviate withdrawal symptoms
when they are unable to source their drug of choice.10 In
contrast, patients citing stimulants (e.g. cocaine) as their
primary drug may use benzodiazepines as part of a
stimulant/depressant cycle, to ease stimulant-withdrawal
symptoms, or to soften the edge of a stimulant ‘high’.10
The second most frequently reported class of medicines
misused in Cape Town is OTC/prescription analgesics. Once
again, this is consistent with international findings.2 Codeine-
containing analgesics are the most commonly misused
analgesics, of which a substantial proportion are OTC
medicines. 
Our study provides good evidence that OTC/prescription
medicine abuse places a considerable burden on the health and
social services of the Western Cape. OTC/prescription
medicine abuse does not receive the same media, or indeed
medical, attention as illicit drugs. However, given their
widespread availability and their acceptance by the broader
community, OTC/prescription medicine abuse may be more
harmful to society than previously thought. Clinicians,
researchers and policy-makers have a responsibility to raise
awareness of the problem among themselves and within the
broader public. General practitioners and pharmacists may
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need to be better trained to detect, manage, and refer people
who misuse OTC/prescription medicines. Given the potential
of codeine-containing medicines to be abused, and since
codeine and similar opioid-type agents (e.g. noscapine,
pholcodine) are present in numerous combination analgesics
and cough suppressants available without a prescription, the
issue of whether codeine-containing OTC medicines should be
rescheduled needs to be considered and carefully debated.  We
also need to improve research efforts to describe the use of
OTC/prescription medicine within the general population by
conducting national household surveys and community-based
studies, as data from treatment facilities are probably poor
estimates of the prevalence of medicine misuse among the
general population.  
This study does, however, have one main methodological
limitation.  Given that data are derived from treatment settings
only, it is possible that a selection bias may be present.  More
specifically, treatment centre data may reflect admission
policies, differential access to services based on socio-economic
status, and the limited availability of treatment services for
marginalised groups rather than a fair representation of
treatment demand for OTC/prescription medicine misuse by
the community. In addition, as mentioned previously, it is
questionable whether findings derived from the treatment
context are reflective of medicine misuse in the general
population.  If anything, patterns of medicine misuse within
the general population would be greater than what we have
observed. 
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